Cyprodenate
|  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| ATC code | N06BX04 | 
| Identifiers | |
| 
 | |
| CAS Number | 15585-86-1  Y | 
| PubChem (CID) | 71875 | 
| ChemSpider | 64892  Y | 
| UNII | I44VIC13P8  Y | 
| KEGG | D07764  Y | 
| ChEMBL | CHEMBL2106590 | 
| ECHA InfoCard | 100.036.025 | 
| Chemical and physical data | |
| Formula | C13H25NO2 | 
| Molar mass | 227.34 | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
| (verify) | |
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite, and so might be expected to produce nootropic effects.
See also
References
- ↑ Dormard Y, Levron JC, Le Fur JM. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):201–7. PMID 1173033.
- ↑ Bobkov Yu.G., Morozov I.S.. Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychoenergizers. Bulletin of Experimental Biology and Medicine. 1982 Oct;94(4):1366-1369. English. doi:10.1007/BF00827201.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.